about
Heat Shock Protein-Peptide and HSP-Based Immunotherapies for the Treatment of CancerHigh molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapyRole of vaccine therapy for renal cell carcinoma in the era of targeted therapyThe Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer TherapeuticsHyperthermia as an immunotherapy strategy for cancerIdentification of peptide mimotopes of gp96 using single-chain antibody library.Separation and identification of HSP-associated protein complexes from pancreatic cancer cell lines using 2D CN/SDS-PAGE coupled with mass spectrometry.Targeting hepatitis B virus antigens to dendritic cells by heat shock protein to improve DNA vaccine potency.HSPPC-96 vaccine in metastatic melanoma patients: from the state of the art to a possible future.Heat shock proteins as emerging therapeutic targets.New targeted therapies in pancreatic cancer.Immunotherapy updates in pancreatic cancer: are we there yet?Immunotherapy of cancer: from monoclonal to oligoclonal cocktails of anti-cancer antibodies: IUPHAR Review 18.Integrating a 'danger' signal into molecular chaperoning to improve vaccination against cancer.The role of stress proteins in prostate cancer.Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease.The immunological era in melanoma treatment: new challenges for heat shock protein-based vaccine in the advanced disease.Heat-shock proteins-based immunotherapy for advanced melanoma in the era of target therapies and immunomodulating agents.Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.Arctigenin from Fructus Arctii is a novel suppressor of heat shock response in mammalian cells.Pancreatic cancer: Update on immunotherapies and algenpantucel-L.Comparison of the anti-tumor effects of various whole-body hyperthermia protocols: correlation with HSP 70 expression and composition of splenic lymphocytes.Novel Immunotherapeutics for the Treatment of Glioblastoma: The Last Decade of Research.
P2860
Q26747392-8E81097F-6205-4743-A1CE-207E092B9A56Q26853566-0ABDDCB5-DC8A-4DE7-9156-C54AAF24A84DQ27016032-9C7DAD70-4E43-4111-95FE-F3B055863048Q27026256-B5A51331-623F-4233-9BD9-B34C4B91EF05Q33686985-FDC003F6-30AE-46E6-BE99-B66F0BB0A940Q33720789-3801C72A-48E1-4F2A-B993-8C0C0D710AA1Q34057985-CFF47E71-AD08-4EB2-9079-52238F1FACF1Q34382810-84DBEF4A-ABAF-4648-957D-A4C62C84212AQ35009889-036B6604-8FF3-4D1F-B67B-03255555D5F0Q35545091-CA64A36B-C20D-4C45-959A-F8CEC1EC8E6FQ35651453-EF38A183-690F-4A6C-AE48-26EC2A2D9F93Q36515532-BB4A824F-AE2C-42BA-A67D-F4BAE88DC1EAQ36797398-3549DE63-BD71-40D5-8F83-C7DC6C54E10FQ36929632-5C58F505-4359-4DC9-9114-46C6A94C1127Q37223453-15EC9C0C-3E73-4847-9602-4238AB4F9629Q37412334-4DB9EA45-ACA0-4FC1-86AC-1A4C729FA7DDQ37892594-03A3A46C-604A-4D65-9D6A-DE0F65092EAEQ37908142-10AEB595-84AA-4230-8BCF-026DCC3BE62CQ38199545-AEF94E3E-658F-41EB-8A5F-50F3496C98FFQ40161313-2ABDF8A8-6E8D-4A79-8583-E561D63C7314Q40260251-33A4E284-7659-4EB3-A94A-150CC319E3BEQ40261599-C2930206-58BA-44C1-AEFC-29087A783EFBQ40379012-00F94856-5338-4308-8E63-86302E745EC3Q52564518-E235A9E0-83A3-4D1F-9272-6EB4F9A29A67
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Heat shock protein-based cancer vaccines.
@ast
Heat shock protein-based cancer vaccines.
@en
type
label
Heat shock protein-based cancer vaccines.
@ast
Heat shock protein-based cancer vaccines.
@en
prefLabel
Heat shock protein-based cancer vaccines.
@ast
Heat shock protein-based cancer vaccines.
@en
P2860
P356
P1476
Heat shock protein-based cancer vaccines.
@en
P2093
Anas Younes
Yasuhiro Oki
P2860
P304
P356
10.1586/14760584.3.4.403
P577
2004-08-01T00:00:00Z